the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116: 654–663. CIRCULATIONAHA.106.672451 [pii];10.1161/CIRCULATIO- NAHA.106.672451 [doi]. 24. Frederick JR, Fitzpatrick JR, III, McCormick RC, Harris DA, Kim AY, et al. (2010) Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocar- dial infarction by inducing neovasculogenesis. Circulation 122: S107–S117. 122/11_suppl_1/S107 [pii];10.1161/CIRCULATIONAHA.109.930404 [doi]. 25. Chen JX, Lawrence ML, Cunningham G, Christman BW, Meyrick B (2004) HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J Appl Physiol 96: 612–620. 26. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460–463. 27. Suchting S, Freitas C, le NF, Benedito R, Breant C, et al. (2007) Negative regulators of vessel patterning. Novartis Found Symp 283: 77–80. 28. High FA, Jain R, Stoller JZ, Antonucci NB, Lu MM, et al. (2009) Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J Clin Invest 119: 1986–1996. 29. Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6: 149–161. 30. Joutel A, Monet-Lepretre M, Gosele C, Baron-Menguy C, Hammes A, et al. (2010) Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 120: 433–445. 31. rboleda-Velasquez JF, Zhou Z, Shin HK, Louvi A, Kim HH, et al. (2008) Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A 105: 4856–4861. 32. Morrow D, Cullen JP, Cahill PA, Redmond EM (2007) Cyclic strain regulates the Notch/CBF-1 signaling pathway in endothelial cells: role in angiogenic activity. Arterioscler Thromb Vasc Biol 27: 1289–1296. 33. Morrow D, Cullen JP, Cahill PA, Redmond EM (2008) Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway. Cardiovasc Res 79: 313–321. 34. O’Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, et al. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136: 355–360. Ang-1 Reduces Myocardial Infarction in db/db Mice 35. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471–476. 36. Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, et al. (2009) Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30: 1144–1152. 37. Kunduzova O, Alet N, esque-Touchard N, Millet L, Castan-Laurell I, et al. (2008) Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J 22: 4146–4153. 38. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, et al. (2008) Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103: 432–440. 39. Quazi R, Palaniswamy C, Frishman WH (2009) The emerging role of apelin in cardiovascular disease and health. Cardiol Rev 17: 283–286. 40. Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, et al. (2008) Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27: 522–534. 41. Nahrendorf M, Pittet MJ, Swirski FK (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437– 2445. 121/22/2437 [pii];10.1161/CIRCULATIONAHA.109.916346 [doi]. 42. Kim SW, Kim H, Yoon YS (2011) Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med 6: 335-349. 10.2217/rme.11.24 [doi]. 43. Kim SW, Kim H, Cho HJ, Lee JU, Levit R, et al. (2010) Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol 56: 593–607. S0735-1097(10)02101-7 [pii];10.1016/j.jacc.2010.01.070 [doi]. 44. Zubair AC, Malik S, Paulsen A, Ishikawa M, McCoy C, et al. (2010) Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells. Cytotherapy 12: 178–189. 45. Doi H, Iso T, Shiba Y, Sato H, Yamazaki M, et al. (2009) Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle- like cells during arterial lesion formation. Biochem Biophys Res Commun 381: 654–659. PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e35905